NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/22/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization101,899 mln
Float1,996 mln
Earnings Date07/29/2026
EPS
3.82
Solid
P / E
13.45
Fair value
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.43
Borderline
1-Year Forecast
57.67
Modest upside
Relative Strength
85
/ 100
Strongly outperforming
Business Description
GSK is a global healthcare company based in London that develops, manufactures, and sells vaccines, specialty medicines, and general medicines to help prevent and treat a wide range of diseases. Its product portfolio covers areas such as cancer, HIV, respiratory conditions, and infectious diseases, as well as vaccines protecting against illnesses like shingles, meningitis, and hepatitis. The company also partners with other organizations to advance new treatments, including mRNA vaccines and therapies for tuberculosis. Originally founded in 1715 and formerly known as GlaxoSmithKline, GSK operates across the United Kingdom, the United States, and many other countries worldwide.
